Warner Bros. Discovery, Inc. (NASDAQ:WBD – Get Rating) has earned an average recommendation of “Moderate Buy” from the sixteen brokerages that are presently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and twelve have given a buy recommendation to the […]
John Hancock Hedged Equity & Income Fund (NYSE:HEQ – Get Rating) was the target of a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 5,200 shares, an increase of 136.4% from the May 15th total of 2,200 shares. Based on an average daily volume […]
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Rating) has earned an average rating of “Moderate Buy” from the thirteen research firms that are presently covering the stock, MarketBeat.com reports. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average twelve-month target price among brokers […]
683 Capital Management LLC lessened its stake in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Rating) by 41.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,000,000 shares of the biotechnology company’s stock after selling 705,000 shares during the period. 683 Capital Management LLC […]